The table below shows Barinthus Biotherapeutics plc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
$0.00
-
-
$14.97M
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$3.59M
$5.39M
$7.95M
$8.29M
$11.14M
$11.66M
SG&A
BRNS annual revenue (10-K history)
Barinthus Biotherapeutics plc. reported annual revenue of $0.00 for fiscal year 2025. That is down 100.0% from $14.97M in fiscal 2024. Over the 6 fiscal years shown, annual revenue declined from $4.82M (FY 2020) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.